Product Information
TIAGABINE HCL 2 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.9228 per EA under NDC 62756020083. Its NADAC has been published 440 times since Nov 28, 2013.
FDA first approved this application on Nov 4, 2011.
Strength
2 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756020083
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077555FDA Approved
11/4/2011
On Market Since
11/4/2011
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 2 MG TABLET has been published 440 times since Nov 28, 2013, and over the history we have for it it has declined 63.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9228 per EA |
|---|---|
| All-time high | $5.6936 (Feb 11, 2015) |
| All-time low | $1.8603 (Jul 17, 2024) |
| 52-week high | $2.1022 |
| 52-week low | $1.9228 |
| Median price | $5.0499 |
| Average price | $4.2304 |
| Largest weekly change | -47.4% (Jan 17, 2024) |
| Weeks tracked | 440 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-8.5%
3Y
-55.7%
5Y
-55.7%
All
-63.4%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TIAGABINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TIAGABINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 2 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $1.9228 per EA (NDC 62756020083), effective Feb 18, 2026.
How has the price of TIAGABINE HCL 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 2 MG TABLET has declined 63.4%. It has been tracked across 440 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 2 MG TABLET?
Since Nov 28, 2013, the NADAC for TIAGABINE HCL 2 MG TABLET has ranged from a low of $1.8603 (Jul 17, 2024) to a high of $5.6936 (Feb 11, 2015), with a median of $5.0499 per EA.
Are there cheaper alternatives to TIAGABINE HCL 2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TIAGABINE HCL 2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIAGABINE HCL 2 MG TABLET?
TIAGABINE HCL 2 MG TABLET (NDC 62756020083) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.